Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phi Sciences is a wellness and biotechnology company founded by Dr. G. Patrick Flanagan, focusing on advanced hydration and antioxidant research. The company is best known for its proprietary Flanagan Microcluster technology, which utilizes nanostructured silica to enhance the bioavailability of nutrients and improve cellular hydration. Their flagship products, MegaHydrate and Crystal Energy, are marketed as powerful silica-based antioxidants that release negatively charged hydrogen ions to reduce oxidative stress and promote longevity. Based in Arizona, Phi Sciences continues to develop and distribute health supplements rooted in Flanagan's theories on structured water and biophysics. The company's products are used globally by consumers seeking to optimize metabolic health and cellular function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phi Sciences.